Glypican 2

Glypican 2

Glypican 2 Overview

Molecule Name
Glypican-2
Synonyms
Glypican 2,GPC2
Drug Development Progress
Drugs in Clinical Trials2
Approved Drugs0
Highest Development StagePhase 1 Clinical
Target Synonym
Cerebroglycan,Glypican Proteoglycan 2, Cerebroglycan Proteoglycan
Background
Glypican 2 (GPC2), also known cerebroglycan, is a glycophosphatidylinositol-linked integral membrane heparan sulfate proteoglycan found in the developing nervous system. Cerebroglycan participates in cell adhesion and is thought to regulate the growth and guidance of axons. Cerebroglycan has especially high affinity for laminin-1. GPC2 silencing inactivates Wnt/β-catenin signaling and reduces the expression of N-Myc, an oncogenic driver of neuroblastoma tumorigenesis. Immunotoxins and chimeric antigen receptor (CAR) T cells targeting GPC2 inhibit neuroblastoma growth in mouse models. A GPC3 specific antibody drug conjugate (ADC) can also inhibit neuroblastoma cell proliferation.

Glypican 2 Product List

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
anti-glypican-2 CAR T-cell therapy (Childrens Hospital of Philadelphia/Kite Pharma)Phase 1 ClinicalChildrens Hospital of Philadelphia
Rhabdomyosarcoma; Small Cell Lung Carcinoma; Urinary Bladder Neoplasms; Neuroblastoma
Details
GPC2 CAR-T cell therapy(Childrens Hospital of Philadelphia/Tmunity Therapeutics)TmGPC2-01-CAR-TPhase 1 ClinicalChildrens Hospital of Philadelphia
Small Cell Lung Carcinoma; Urinary Bladder Neoplasms; Neuroblastoma
Details